| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0036 |
0.9 |
| mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |